Drugmakers this week did not purchase experimental drug candidates but invested in approved drugs and a factory that makes imaging agents.

ByVicky Ge Huang As bond yields march higher, small companies are taking the brunt of the damage. The Russell 2000 index, ...

The stock's rise snapped a three-day losing streak. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the ...

On the day U.S. regulators tied a defect in Philips' handheld Lumify ultrasound to four deaths and eight serious injuries, the stock fell about a quarter of one percent. That gap - between a headline ...

Following its spinoff from General Electric, GE HealthCare Technologies Inc. (NASDAQ:GEHC) has evolved from an established hardware developer into an AI-led, high-margin medtech player. The company ...